HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


"Don't Fret the Sweat"

This article was originally published in The Rose Sheet

Executive Summary

Unilever refers parents of tweens to DontFretTheSweat.com, its educational Web site "filled with expert tips, money-saving offers and real-life stories about how parents are communicating and transitioning their tweens into confident and self-reliant young adults." In a survey conducted by KRC Research, 69% of tweens characterized talks with their parents as "very helpful," firm notes. It states: "In addition to facing more challenges and pressures, supporting research shows that kids are also entering puberty and experiencing biological milestones - including producing body odor - at an earlier age." Among other offerings from its Degree, Dove and Suave deodorant and antiperspirant lines, Unilever recommends Degree Girl, which "gets girls through every OMG moment with confidence" and now comes in a new scent - Degree Girl Friends Forever

You may also be interested in...

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement

The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.

Novo Nordisk Targets Smart Insulin, Stem Cell-Therapies

Novo Nordisk’s CEO talks to Scrip about the promise of glucose-responsive insulin, stem cell therapy, and a diabetes landscape without Sanofi.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts